Objective Recently, circulating donor-derive cell free DNA (dd-cfDNA) has gained growing
attention in the field of solid organ transplantation. The aim of the study was to analyze …

Lung transplantation has become the definitive treatment for end stage respiratory disease.
Numbers and survival rates have increased over the past decade, with transplant recipients …

In lung transplantation, antibody-mediated rejection (AMR) diagnosed using the
International Society for Heart and Lung Transplantation criteria is uncommon compared …

Identification of recipients with pre-existing antibodies and cross-matching of recipient sera
with donor lymphocytes have reduced the incidence of antibody-mediated rejection (AMR) …

Procrustes, the ancient Greek mythologic villain who resized his visitors to fit an iron bed,
serves as a macabre allegory of the risks of applying a rigid framework to new scenarios. 1 …

Background The association between organizing pneumonia (OP) after lung transplantation
with the development of acute rejection (AR) remains undefined. In addition, molecular …

Abstract Treatment options for end stage lung diseases are limited to stabilizing lung failure,
decreasing disease progression, and symptom management, but significant reversal of lost …

Advances in the use of molecular biomarkers to guide management of lung transplant
recipients are emerging. One such biomarker, donor-derived cell-free DNA (dd-cfDNA), has …